Evidence map›Paper›PMID 39967870›Full record

ArticleiScience2025

Eliana Drenkard, Christian Godfrey, Alex Hopke, Sujatha Rajeev Thundivalappil, Michael Chen Li, Daniel Irimia, Bryan P Hurley

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eliana DrenkardMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston MA 02114, USA.
Christian GodfreyHarvard Medical School, Boston, MA 02115, USA.
Alex HopkeHarvard Medical School, Boston, MA 02115, USA.
Sujatha Rajeev ThundivalappilMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston MA 02114, USA.
Michael Chen LiMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston MA 02114, USA.
Daniel IrimiaHarvard Medical School, Boston, MA 02115, USA.
Bryan P HurleyMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston MA 02114, USA.

Funding

The Role of Hepoxilin A3 in Neutrophil Breach of the Infected Airway MucosaR01AI095338 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HURLEY, BRYAN P · 2012 to 2022
$5.2M
In vivo Monitoring of Neutrophil Function in Patients after Stem Cell TransplantR01AI176658 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel Irimia, Charles P. Lin · 2023 to 2026
$3.2M
MGHfC Digestive Disease Summer Research ProgramR25DK103579 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BRYAN P HURLEY · 2015 to 2026
$1.2M
NIAID NIH HHS R01 AI095338NIAID NIH HHS R01 AI176658NIDDK NIH HHS R25 DK103579
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical MicrobiologyMicrobiology

Identifiers

PMID39967870
PMCPMC11834114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.